Delivery Order SPE2DB20D1102-SPE2DB25FC6GJ

Award Date 5/15/25
Potential Completion Date 5/16/25
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET XR 100-1,000 MG tablets for a total ceiling value of $1,086.48. It is a firm fixed-price delivery order contract with a performance period through January 14, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a large...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $32,321.13, is a delivery order for JANUMET XR 50-1,000 MG TABLET 180S. It has an ultimate completion date of March 6, 2025 and a firm fixed price pricing type. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the provision of Janumet XR 50-1,000 mg tablets. The contract, valued at $1,274.13, is a firm fixed-price delivery order with a completion date of May 29, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,744.17, is for the delivery of JANUMET XR 100-1,000 MG TABLET 90S, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of JANUMET XR 100-1,000 MG tablets, with a ceiling value of $1,667.78 and a performance period through November 16, 2021. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Janumet XR 100-1,000 mg tablets. The contract has a ceiling value of $13,794.87 and is a firm fixed-price delivery order contract with a completion date of May 19, 2025. The contract is not set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Janumet XR 50-1,000 mg tablets. The contract has a ceiling value of $10,498.84 and an ultimate completion date of November 14, 2023. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The Defense Logistics Agency (DLA) awarded a $5,910.05 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Janumet XR 100-1,000 mg tablets. The contract has an ultimate completion date of January 10, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Janumet XR 100-1,000 mg tablets. The $1,703.73 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to provide a...
This is a delivery order award under a Defense Logistics Agency (DLA) Indefinite Delivery Contract (IDC) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of JANUMET XR 50-1,000 mg tablets. The award has a firm fixed price ceiling value of $10,417.02 and a completion date of March 4, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant IDC with the DLA Troop Support Medical, valued at...
  • SPE2DB20D1102
    Indefinite Delivery Contract
  • SPE2DB20D1102-SPE2DB25FC6GJ
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Janumet XR 100-1,000 MG tablets. The contract is a firm fixed-price delivery order with a ceiling value of $3,581.21 and a completion date of May 16, 2025. The contract is not set aside for any specific business type.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 8/14/25, 10:01 AM